Young Physician RLT Academy

Dear Doctor,

Radioligand therapy (RLT) is becoming an important pillar of cancer care globally. To meet the need for widespread patient access to this therapy, there is a need to attract younger physicians to this area of medicine. Further, patient access in Switzerland will only be secured through strong multidisciplinary collaboration between oncologists and nuclear medicine physicians keeping up with the rapidly evolving clinical science. The objective of this event is therefore to train and connect young oncologists and nuclear medicine physicians interested in making RLT an essential pillar of oncology treatment.

Come and help us shape the future of cancer care in Switzerland!

We look forward to your attendance.

27 November 2026
Evenito AG

3 SGNM CME credits

3 Travel Awards – Apply now!

This year we will be awarding three travel awards to attend the ASCO, ESMO and EANM conferences:

· ASCO 2026, April 29 – May 2, Chicago, USA

· EANM 2025, October 17-21, Vienna, Austria

· ESMO 2026, October 23-27, Madrid, Spain

What can you expect from the award?

  • Mentorship

  • Travel, accommodation and registration fees*

*while adhering to 33% co-payment rule as outlined in Swiss Ordinance VITH

You must fulfill at least 2 of the following criteria:

  • Have a nuclear medicine FMH title

  • Be an experienced speaker involved in previous events

  • Have published research in RLT/nuclear medicine

  • Have been an investigator on clinical trials

  • Have treated a significant number of patients with RLT

  • Have been involved in local/international guidelines

  • Are a board member of a medical society

Apply by April 17th

Send your CV, motivation letter & letter of recommendation to gabriela.fosado_wyhooge@novartis.com. The steering committee will select the winners based on academic standing (i.e. the criteria listed above). Applicants should be in residency or have completed their FMH title in the last 5 yrs from the application deadline. Travel award winners will have the privilege of presenting their highlights of ASCO/ESMO/EANM at this event under the mentorship of Prof Schaefer.

Steering Committee

Valentina Garibotto
Prof Dr

HUG, Geneva

Magdalena Kulgawczuk
Dr

Inselspital, Bern

Aurelius Omlin
PD Dr

Onkozentrum, Zürich

Niklaus Schaefer
Prof Dr

CHUV, Lausanne

Michael Wissmeyer
PD Dr

Bürgerspital Solothurn

Anja Lorch
Prof Dr

USZ, Zürich

Schedule

14:00 - 14:05
Welcome & Introduction

Chairs: Drs Omlin & Schaefer

14:05 - 14:35
ASCO highlights (20 + 10 min)

Nucl Med - TBD

14:35 - 15:05
ESMO highlights (20 + 10 min)

Oncologist - TBD

15:05 - 15:35
EANM highlights (20 + 10 min)

Nucl Med - TBD

15:35 - 16:00
-------- Networking time ---------

Chair: Dr Wissmeyer

16:00 - 17:30
Workshop – Case discussions

3 cases @ 30 min (NM/Onc)

NM & Onco Case 1

NM & Onco Case 2

NM & Onco Case 3

17:30 - 18:00
-------- Networking time ---------

Chairs: Drs Lorch & Garibotto

18:00 - 18:25
Swiss PSMA PET/RLT Guidelines: An Update

Dr Burger, KSB/USZ/ETH

18:25 - 18:50
Swiss National RLT Stakeholder Initiative: An Update

Dr Schaefer, CHUV

18:50 - 19:00
--- Closing followed by Apero --

Location to be determined. Stay tuned for upates!

Evenito AG

Hafnerstrasse 24
8005 Zürich

Accusantium aliquid non neque dicta eum. Molestias nesciunt odit. Quis rerum et cumque distinctio a pariatur vel ea dicta.

Registration